⌘K

Login Start Free

Home/Filings/4/0001694665-22-000087

4//SEC Filing

McHale Duncan 4

Accession 0001694665-22-000087

CIK 0001694665other

View on SEC.gov Company Profile

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:15 PM ET

Size

4.5 KB

Accession

0001694665-22-000087

Insider Transaction Report

Form 4

Period: 2022-05-27

Evelo Biosciences, Inc.EVLO

Chief Medical Officer

Transactions

Purchase
Common Stock
2022-05-27$1.46/sh+34,246$49,999→ 34,246 total

Documents

1 file

4
wf-form4_165402808473244.xmlPrimary
FORM 4

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1

filerCIK 0001738896

Filing Metadata

Form type: 4
Filed: May 30, 8:00 PM ET
Accepted: May 31, 4:15 PM ET
Size: 4.5 KB

View on SEC.gov